Literature DB >> 28882947

Expression of Cyclooxygenase-2, Nitric Oxide Synthase 2 and Heme Oxygenase-1 mRNA Induced by Bis-Eugenol in RAW264.7 Cells and their Antioxidant Activity Determined Using the Induction Period Method.

Yukio Murakami1, Akifumi Kawata2, Seiichiro Fujisawa2.   

Abstract

BACKGROUND/AIM: To clarify the mechanisms responsible for the anti-inflammatory/proinflammatory activities of eugenol-related compounds, we investigated the cytotoxicity and up-regulatory/down-refgulatory effects of the biphenols curcumin, bis-eugenol, magnolol and honokiol, and the monophenols eugenol and isoeugenol, on major regulators of cyclooxygenase-2 (Cox-2), nitric oxide synthase 2 (Nos2) and heme oxygenase-1 (HO-1) mRNA in RAW264.7 cells.
MATERIALS AND METHODS: mRNA expression was investigated using real-time reverse transcriptase-polymerase chain reaction (RT-PCR), and the theoretical parameters were calculated using the DFT/B3LYP/6-31* method. Also, the antioxidant activity of eugenol-related compounds in combination with 2-mercapto-1-methylimidazole (MMI, as a model for glutathione (GSH)) was investigated using the induction period method for polymerization of methyl methacrylate initiated by benzoyl peroxide (BPO).
RESULTS: The cytotoxicity of eugenol-related compounds showed a linear relationship with their softness (σ) and electrophilicity (ω). At a concentration of 50 μM, biphenols except for bis-eugenol elicited the expression of mRNA for both Cox-2 and Nos2, but monophenols did not. In contrast, bis-eugenol elicited Cox-2 gene expression, but down-regulated Nos2 gene expression. bis-Eugenol alone induced the expression of HO-1 mRNA, and when combined with MMI it showed a potent antagonistic effect on BPO-induced antioxidant activity. The ability of methoxyphenols to inhibit LPS-stimulated Cox-2 gene expression declined in the order curcumin >> isoeugenol > bis-eugenol >> eugenol, and the rank of ability was related to their ω value.
CONCLUSION: Most eugenol-related compounds had proinflammatory activity at high concentrations. However, they had also anti-inflammatory activity at lower concentrations. Eugenol-related compounds may exert antioxidant and anti-inflammatory activity in LPS-stimulated RAW264.7 cells possibly by inhibiting the activation of nuclear factor-kappa B (Nf-ĸB), whereas bis-eugenol requires induction of HO-1 expression. bis-Eugenol as well as curcumin, may have anti-inflammatory and anticancer therapeutic applications. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  COX-2; Eugenol-related compounds; HO-1; NOS2; RAW264.7 cells; antioxidants; theoretical parameters

Mesh:

Substances:

Year:  2017        PMID: 28882947      PMCID: PMC5656854          DOI: 10.21873/invivo.11135

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  42 in total

1.  Interaction between eugenol-related compounds and radicals.

Authors:  K Satoh; H Sakagami; I Yokoe; M Kochi; S Fujisawa
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

2.  Contact allergy to isoeugenol and its derivatives: problems with allergen substitution.

Authors:  S Tanaka; C Royds; D Buckley; D A Basketter; A Goossens; M Bruze; C Svedman; T Menné; J D Johansen; I R White; J P McFadden
Journal:  Contact Dermatitis       Date:  2004 Nov-Dec       Impact factor: 6.600

3.  Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics.

Authors:  Giuseppe Galati; Omid Sabzevari; John X Wilson; Peter J O'Brien
Journal:  Toxicology       Date:  2002-08-01       Impact factor: 4.221

Review 4.  Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity.

Authors:  Seiichiro Fujisawa; Toshiko Atsumi; Yoshinori Kadoma; Hiroshi Sakagami
Journal:  Toxicology       Date:  2002-08-01       Impact factor: 4.221

Review 5.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

6.  Mechanisms of cytotoxicity of 2- or 2,6-di-tert-butylphenols and 2-methoxyphenols in terms of inhibition rate constant and a theoretical parameter.

Authors:  Yoshinori Kadoma; Shigeru Ito; Toshiko Atsumi; Seiichiro Fujisawa
Journal:  Chemosphere       Date:  2008-12-11       Impact factor: 7.086

Review 7.  Studies on free radicals, antioxidants, and co-factors.

Authors:  Khalid Rahman
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

8.  Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.

Authors:  Santosh K Sandur; Manoj K Pandey; Bokyung Sung; Kwang Seok Ahn; Akira Murakami; Gautam Sethi; Pornngarm Limtrakul; Vladimir Badmaev; Bharat B Aggarwal
Journal:  Carcinogenesis       Date:  2007-05-23       Impact factor: 4.944

Review 9.  A review on antibacterial, antiviral, and antifungal activity of curcumin.

Authors:  Soheil Zorofchian Moghadamtousi; Habsah Abdul Kadir; Pouya Hassandarvish; Hassan Tajik; Sazaly Abubakar; Keivan Zandi
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

Review 10.  ROS and ROS-Mediated Cellular Signaling.

Authors:  Jixiang Zhang; Xiaoli Wang; Vikash Vikash; Qing Ye; Dandan Wu; Yulan Liu; Weiguo Dong
Journal:  Oxid Med Cell Longev       Date:  2016-02-22       Impact factor: 6.543

View more
  3 in total

1.  Cytotoxicity and Pro-/Anti-inflammatory Properties of Cinnamates, Acrylates and Methacrylates Against RAW264.7 Cells.

Authors:  Yukio Murakami; Akifumi Kawata; Seiji Suzuki; Seiichiro Fujisawa
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

2.  Development of a MD-LC-MS/MS Method to Analyze 3 Bioactive Compounds in Huoxuezhitong Rubber Patch and Application to a Pharmacokinetic Study in Rats.

Authors:  Yahua Cui; Chang Yang; Jun Liang; Linying Zhong; Caifeng Liu; Jie Bai; Shouying Du; Daofang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-17       Impact factor: 2.650

Review 3.  Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions.

Authors:  Bala Mohan Sivani; Mahmoud Azzeh; Rajashree Patnaik; Anca Pantea Stoian; Manfredi Rizzo; Yajnavalka Banerjee
Journal:  Metabolites       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.